Innovation

We are excited to share that our Early Phase Unit in Manchester dosed the first participant in Small Pharma’s first-in-human

The placebo response or the placebo effect. We hear about it a lot, but what happens in practise? Let’s unravel

At MAC we have expertise in a wide range of different areas including Men and Women’s Health. One of these

The next generation of treatment? Could psychedelic research be a promising new step in treating mental health disorders like depression,

A new drug developed by Lancaster University which may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials. Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.